Biscarbene gold(i) complexes: structure-activity-relationships regarding antibacterial effects, cytotoxicity, TrxR inhibition and cellular bioavailability.
暂无分享,去创建一个
B. Karge | A. Prokop | M. Brönstrup | I. Ott | C. Schmidt | Rainer Misgeld | Bianka Karge
[1] B. Karge,et al. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects. , 2017, Chemistry.
[2] D. Schuppan,et al. Ferrocenyl-Coupled N-Heterocyclic Carbene Complexes of Gold(I): A Successful Approach to Multinuclear Anticancer Drugs. , 2016, Chemistry.
[3] R. Gust,et al. Update on metal N-heterocyclic carbene complexes as potential anti-tumor metallodrugs , 2016 .
[4] A. Casini,et al. Determinants for Tight and Selective Binding of a Medicinal Dicarbene Gold(I) Complex to a Telomeric DNA G-Quadruplex: a Joint ESI MS and XRD Investigation. , 2016, Angewandte Chemie.
[5] M. Sanaú,et al. Versatile synthesis of cationic N-heterocyclic carbene-gold(i) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium-gold anticancer agents. , 2016, Chemical communications.
[6] C. Che,et al. Chemical biology of anticancer gold(III) and gold(I) complexes. , 2015, Chemical Society reviews.
[7] V. Lynch,et al. Targeting antioxidant pathways with ferrocenylated N-heterocyclic carbene supported gold(i) complexes in A549 lung cancer cells , 2015, Chemical science.
[8] M. H. Franz,et al. N-heterocyclic carbenes (NHC) with 1,2,4-oxadiazole-substituents related to natural products: synthesis, structure and potential antitumor activity of some corresponding gold(I) and silver(I) complexes. , 2015, European journal of medicinal chemistry.
[9] M. Balzi,et al. Evidence that the antiproliferative effects of auranofin in Saccharomyces cerevisiae arise from inhibition of mitochondrial respiration. , 2015, The international journal of biochemistry & cell biology.
[10] A. Casini,et al. Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents , 2015, JBIC Journal of Biological Inorganic Chemistry.
[11] I. Ott,et al. A novel aminotriazole-based NHC complex for the design of gold(I) anti-cancer agents: synthesis and biological evaluation , 2015 .
[12] P. Schultz,et al. Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis , 2015, Proceedings of the National Academy of Sciences.
[13] S. Wölfl,et al. A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells , 2014, Molecular Cancer.
[14] T. Muth,et al. Auranofin and related heterometallic gold(I)-thiolates as potent inhibitors of methicillin-resistant Staphylococcus aureus bacterial strains. , 2014, Journal of inorganic biochemistry.
[15] C. Che,et al. A binuclear gold(I) complex with mixed bridging diphosphine and bis(N-heterocyclic carbene) ligands shows favorable thiol reactivity and inhibits tumor growth and angiogenesis in vivo. , 2014, Angewandte Chemie.
[16] D. Schuppan,et al. Gold(I) Biscarbene Complexes Derived from Vascular‐Disrupting Combretastatin A‐4 Address Different Targets and Show Antimetastatic Potential , 2014, ChemMedChem.
[17] A. Casini,et al. Cytotoxic Gold(I) N‐heterocyclic Carbene Complexes with Phosphane Ligands as Potent Enzyme Inhibitors , 2014, ChemMedChem.
[18] L. Messori,et al. Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections , 2014, BioMetals.
[19] R. Rubbiani,et al. Historical and biochemical aspects of a seventeenth century gold-based aurum vitae recipe , 2014, JBIC Journal of Biological Inorganic Chemistry.
[20] M. Djuran,et al. Gold complexes as antimicrobial agents: an overview of different biological activities in relation to the oxidation state of the gold ion and the ligand structure. , 2014, Dalton transactions.
[21] J. Lazo,et al. Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity. , 2014, ACS chemical biology.
[22] A. Casini,et al. A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds. , 2014, Dalton transactions.
[23] Benoît Bertrand,et al. Caffeine-based gold(I) N-heterocyclic carbenes as possible anticancer agents: synthesis and biological properties. , 2014, Inorganic chemistry.
[24] R. Rubbiani,et al. TrxR inhibition and antiproliferative activities of structurally diverse gold N-heterocyclic carbene complexes , 2013 .
[25] L. Engstrand,et al. Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] Peter Gölitz,et al. Cover Picture: Champagne and Fireworks: Angewandte Chemie Celebrates Its Birthday (Angew. Chem. Int. Ed. 1/2013) , 2013 .
[27] M. Arkin,et al. A high throughput drug screen for Entamoeba histolytica identifies a new lead and target , 2012, Nature Medicine.
[28] R. Gust,et al. Synthesis, characterization, and in vitro studies of bis[1,3-diethyl-4,5-diarylimidazol-2-ylidene]gold(I/III) complexes. , 2012, Journal of medicinal chemistry.
[29] S. Wölfl,et al. Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type. , 2011, Journal of medicinal chemistry.
[30] S. Wölfl,et al. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties. , 2010, Journal of medicinal chemistry.
[31] I. Ott,et al. Comparative studies on the cytotoxicity, cellular and nuclear uptake of a series of chloro gold(I) phosphine complexes , 2010 .
[32] A. Miele,et al. Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by Auranofin , 2009, The Journal of Biological Chemistry.
[33] I. Ott. On the medicinal chemistry of gold complexes as anticancer drugs , 2009 .
[34] R. Levine,et al. Auranofin disrupts selenium metabolism in Clostridium difficile by forming a stable Au–Se adduct , 2009, JBIC Journal of Biological Inorganic Chemistry.
[35] James L. Hickey,et al. Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols. , 2008, Journal of the American Chemical Society.
[36] James L. Hickey,et al. Cationic, linear Au(I) N-heterocyclic carbene complexes: synthesis, structure and anti-mitochondrial activity. , 2006, Dalton transactions.
[37] J. Verweij,et al. Comparison of ethanol plasma-protein precipitation with plasma ultrafiltration and trichloroacetic acid protein precipitation for the measurement of unbound platinum concentrations , 1996, Cancer Chemotherapy and Pharmacology.
[38] S. Crooke,et al. Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions. , 1986, Biochemical pharmacology.
[39] T. Mueller,et al. Gold(I)-NHC complexes of antitumoral diarylimidazoles: structures, cellular uptake routes and anticancer activities. , 2012, Journal of inorganic biochemistry.
[40] H. Reile,et al. Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua(1,2-diphenylethylenediamine) platinum(II) sulfates and specific platinum accumulation , 2004, Cancer Chemotherapy and Pharmacology.
[41] R. Gust,et al. Stability and cellular studies of [rac-1,2-bis(4-fluorophenyl)- ethylenediamine][cyclobutane-1,1-dicarboxylato]platinum(II), a novel, highly active carboplatin derivative , 1998, Journal of Cancer Research and Clinical Oncology.